Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated:  9/14/2017
Univ of Washington
2006
mi
from 43215
Seattle, WA
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated: 9/14/2017
Univ of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Characterization of Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Status: Enrolling
Updated:  9/14/2017
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Characterization of Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Status: Enrolling
Updated: 9/14/2017
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated:  9/15/2017
UCLA
1982
mi
from 43215
Los Angeles, CA
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated: 9/15/2017
UCLA
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated:  9/15/2017
Tahseen Mozaffar
1958
mi
from 43215
Orange, CA
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated: 9/15/2017
Tahseen Mozaffar
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated:  9/15/2017
Montreal Neurological Institute, McGill University
612
mi
from 43215
Montreal,
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated: 9/15/2017
Montreal Neurological Institute, McGill University
612
mi
from 43215
Montreal,
Click here to add this to my saved trials
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
Status: Enrolling
Updated:  9/18/2017
East Carolina University
429
mi
from 43215
Greenville, NC
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
Status: Enrolling
Updated: 9/18/2017
East Carolina University
429
mi
from 43215
Greenville, NC
Click here to add this to my saved trials
A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes
Status: Enrolling
Updated:  9/18/2017
Chad J Anderson DMD Inc
1989
mi
from 43215
Fresno, CA
A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes
Status: Enrolling
Updated: 9/18/2017
Chad J Anderson DMD Inc
1989
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Helping Older Persons Emerge Stronger
Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission
Status: Enrolling
Updated:  9/18/2017
The Ohio State University College of Nursing
2
mi
from 43215
Columbus, OH
Helping Older Persons Emerge Stronger
Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission
Status: Enrolling
Updated: 9/18/2017
The Ohio State University College of Nursing
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
481
mi
from 43215
New York, NY
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
414
mi
from 43215
Syracuse, NY
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
414
mi
from 43215
Syracuse, NY
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
348
mi
from 43215
Charlotte, NC
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
307
mi
from 43215
Winston-Salem, NC
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
307
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
7
mi
from 43215
Columbus, OH
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
7
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from 43215
Paris,
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from 43215
Paris,
Click here to add this to my saved trials
Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans
Neuroactive Steroids and TBI in OEF/OIF Veterans
Status: Enrolling
Updated:  9/19/2017
Durham VA Medical Center, Durham, NC
351
mi
from 43215
Durham, NC
Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans
Neuroactive Steroids and TBI in OEF/OIF Veterans
Status: Enrolling
Updated: 9/19/2017
Durham VA Medical Center, Durham, NC
351
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Mayo Clinic
1650
mi
from 43215
Phoenix, AZ
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Mayo Clinic
1650
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Rancho Los Amigos National Rehabilitation Center
1969
mi
from 43215
Downey, CA
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Rancho Los Amigos National Rehabilitation Center
1969
mi
from 43215
Downey, CA
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Shepherd Rehabilitation Center
432
mi
from 43215
Atlanta, GA
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Shepherd Rehabilitation Center
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Rehabilitation Institute of Chicago
274
mi
from 43215
Chicago, IL
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Rehabilitation Institute of Chicago
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Indiana University Indianapolis
167
mi
from 43215
Indianapolis, IN
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Indiana University Indianapolis
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Spaulding Rehabilitation Hospital
643
mi
from 43215
Boston, MA
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Spaulding Rehabilitation Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Columbia Cornell New York Presbyterian Hospital
481
mi
from 43215
New York, NY
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Columbia Cornell New York Presbyterian Hospital
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Burke Medical Research Institute, Weill Cornell Neurology
492
mi
from 43215
White Plains, NY
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Burke Medical Research Institute, Weill Cornell Neurology
492
mi
from 43215
White Plains, NY
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Ohio State University
2
mi
from 43215
Columbus, OH
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
TIRR Memorial Hermann Hospital
996
mi
from 43215
Houston, TX
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
TIRR Memorial Hermann Hospital
996
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memoral Sloan Kettering Cancer Center
449
mi
from 43215
Basking Ridge, NJ
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memoral Sloan Kettering Cancer Center
449
mi
from 43215
Basking Ridge, NJ
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan-Kettering Cancer Center @ Suffolk
515
mi
from 43215
Commack, NY
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan-Kettering Cancer Center @ Suffolk
515
mi
from 43215
Commack, NY
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan Kettering West Harrison
493
mi
from 43215
Harrison, NY
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan Kettering West Harrison
493
mi
from 43215
Harrison, NY
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
AVIDA, Inc.
1963
mi
from 43215
Newport Beach, CA
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
AVIDA, Inc.
1963
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
South Shore Psychiatric Services, PC
657
mi
from 43215
Marshfield, MA
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
South Shore Psychiatric Services, PC
657
mi
from 43215
Marshfield, MA
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism
Status: Enrolling
Updated:  9/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism
Status: Enrolling
Updated: 9/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
Status: Enrolling
Updated:  9/21/2017
Oral Health Research Clinic at the School of Dentistry at the University of Minnesota
624
mi
from 43215
Minneapolis, MN
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
Status: Enrolling
Updated: 9/21/2017
Oral Health Research Clinic at the School of Dentistry at the University of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated:  9/21/2017
4021
mi
from 43215
Gent,
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated: 9/21/2017
4021
mi
from 43215
Gent,
Click here to add this to my saved trials
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated:  9/21/2017
Clinical Research Facility
1919
mi
from 43215
San Bernardino, CA
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated: 9/21/2017
Clinical Research Facility
1919
mi
from 43215
San Bernardino, CA
Click here to add this to my saved trials
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated:  9/21/2017
Johns Hopkins Hospital
345
mi
from 43215
Baltimore, MD
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated: 9/21/2017
Johns Hopkins Hospital
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated:  9/21/2017
Medical University of Vienna
4608
mi
from 43215
Vienna,
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated: 9/21/2017
Medical University of Vienna
4608
mi
from 43215
Vienna,
Click here to add this to my saved trials
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated:  9/22/2017
University of Chicago
270
mi
from 43215
Chicago, IL
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated: 9/22/2017
University of Chicago
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department
Status: Enrolling
Updated:  9/22/2017
The George Washington University Medical Center, Dept of Emergency Medicine
327
mi
from 43215
Washington, D.C.,
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department
Status: Enrolling
Updated: 9/22/2017
The George Washington University Medical Center, Dept of Emergency Medicine
327
mi
from 43215
Washington, D.C.,
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
Stanford University
2100
mi
from 43215
Palo Alto, CA
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
Stanford University
2100
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
Yale University
537
mi
from 43215
New Haven, CT
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
George Washington University
327
mi
from 43215
Washington, D.C.,
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
George Washington University
327
mi
from 43215
Washington, D.C.,
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
University of Miami
992
mi
from 43215
Miami, FL
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
Emory University
435
mi
from 43215
Atlanta, GA
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials